Home > Cell Selection & Expansion > Cell Stimulation & Expansion > Peptides for T cell stimulation

Peptides for T cell stimulation

Our peptides are synthesized as single peptides as presented by the MHC class I allele.

  • peptides of 9-10 amino acids
  • purity > 80 %
  • endotoxin free

Choose between following categories:

  • virus and tumor specific antigens
  • Listeria specific antigens
  • human and murine alleles

NOW AVAILABLE: SARS-CoV-2 peptides for T cell stimulation

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that currently needs detailed research to understand underlying immune responses and to provide possible treatment options. In addition, the development of an efficient vaccine is essential to prevent future outbreaks. Studying CD8+ cytotoxic T cell activation and proliferation in response to different virus-derived peptides can help to identify the parts of a virus that elicit a strong immune response. This information is required for efficient vaccine design and contributes to the understanding of the infection biology. We provide different SARS-CoV-2-derived peptides for T cell stimulation to support the ongoing research regarding the new coronavirus.

Special offer

Save 50%* on all peptide products for T cell stimulation.

*This discount is valid until 30th September 2020. Not valid in combination with other IBA discounts. Distributors and IBA staff excluded.

Products - Collection of peptides

Please use filters "Category" and "Subcategory" to quickly select your product from the list below:


Product Contents Cat.no Price   Order
SARS-CoV-2 peptide ALNTLVKQL (HLA-A*0201) for stimulation of T-cells 1 mg 6-7112-901 USD 80.00

SARS-CoV-2 peptide ALNTLVKQL (HLA-A*0201) for stimulation of T-cells. Single peptide (ALNTLVKQL) for stimulation of human SARS-CoV-2-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free.

SARS-CoV-2 peptide VLNDILSRL (HLA-A*0201) for stimulation of T-cells 1 mg 6-7113-901 USD 80.00

SARS-CoV-2 peptide VLNDILSRL (HLA-A*0201) for stimulation of T-cells. Single peptide (VLNDILSRL) for stimulation of human SARS-CoV-2-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free.

SARS-CoV-2 peptide VVFLHVTYV (HLA-A*0201) for stimulation of T-cells 1 mg 6-7114-901 USD 80.00

SARS-CoV-2 peptide VVFLHVTYV (HLA-A*0201) for stimulation of T-cells. Single peptide (VVFLHVTYV) for stimulation of human SARS-CoV-2-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free.

SARS-CoV-2 peptide ILLNKHIDA (HLA-A*0201) for stimulation of T-cells 1 mg 6-7115-901 USD 80.00

SARS-CoV-2 peptide ILLNKHIDA (HLA-A*0201) for stimulation of T-cells. Single peptide (ILLNKHIDA) for stimulation of human SARS-CoV-2-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free.

SARS-CoV-2 peptide LALLLLDRL (HLA-A*0201) for stimulation of T-cells 1 mg 6-7116-901 USD 80.00

SARS-CoV-2 peptide LALLLLDRL (HLA-A*0201) for stimulation of T-cells. Single peptide (LALLLLDRL) for stimulation of human SARS-CoV-2-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free.

SARS-CoV-2 peptide LLLDRLNQL (HLA-A*0201) for stimulation of T-cells 1 mg 6-7117-901 USD 80.00

SARS-CoV-2 peptide LLLDRLNQL (HLA-A*0201) for stimulation of T-cells. Single peptide (LLLDRLNQL) for stimulation of human SARS-CoV-2-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free.

SARS-CoV-2 peptide LQLPQGTTL (HLA-A*0201) for stimulation of T-cells 1 mg 6-7118-901 USD 80.00

SARS-CoV-2 peptide LQLPQGTTL (HLA-A*0201) for stimulation of T-cells. Single peptide (LQLPQGTTL) for stimulation of human SARS-CoV-2-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free.

SARS-CoV-2 peptide KIADYNYKL (HLA-A*0201) for stimulation of T-cells 1 mg 6-7119-901 USD 80.00
 

SARS-CoV-2 peptide KIADYNYKL (HLA-A*0201) for stimulation of T-cells. Single peptide (KIADYNYKL) for stimulation of human SARS-CoV-2-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free.

SARS-CoV-2 peptide KVGGNYNYL (HLA-A*0201) for stimulation of T-cells 1 mg 6-7120-901 USD 80.00

SARS-CoV-2 peptide KVGGNYNYL (HLA-A*0201) for stimulation of T-cells. Single peptide (KVGGNYNYL) for stimulation of human SARS-CoV-2-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free.

SARS-CoV-2 peptide GYQPYRVVVL (HLA-A*2402) for stimulation of T-cells 1 mg 6-7121-901 USD 80.00

SARS-CoV-2 peptide GYQPYRVVVL (HLA-A*2402) for stimulation of T-cells. Single peptide (GYQPYRVVVL) for stimulation of human SARS-CoV-2-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*2402 allele. Lyophilized powder. Purity > 80 %, endotoxin free.

SARS-CoV-2 peptide PYRVVVLSF (HLA-A*2402) for stimulation of T-cells 1 mg 6-7122-901 USD 80.00

SARS-CoV-2 peptide PYRVVVLSF (HLA-A*2402) for stimulation of T-cells. Single peptide (PYRVVVLSF) for stimulation of human SARS-CoV-2-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*2402 allele. Lyophilized powder. Purity > 80 %, endotoxin free.

SARS-CoV-2 peptide LSPRWYFYY (HLA-A*2402) for stimulation of T-cells 1 mg 6-7123-901 USD 80.00

SARS-CoV-2 peptide LSPRWYFYY (HLA-A*2402) for stimulation of T-cells. Single peptide (LSPRWYFYY) for stimulation of human SARS-CoV-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*2402 allele. Lyophilized powder. Purity > 80 %, endotoxin free.